Metabolomic biomarkers in blood samples identify cancers in a mixed population of patients with nonspecific symptoms
<strong>Purpose:</strong> Early diagnosis of cancer is critical for improving patient outcomes, but cancers may be hard to diagnose if patients present with nonspecific signs and symptoms. We have previously shown that nuclear magnetic resonance (NMR) metabolomics analysis can detect can...
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Journal article |
| Lenguaje: | English |
| Publicado: |
American Association for Cancer Research
2022
|